Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00949884 · ClinicalTrials.gov registry record · Phase 4

Olmesartan Comparison to Losartan in Hypertensive Subjects

A Phase 4 study of Hypertension, sponsored by Daiichi Sankyo.

Completed
Registry status
Phase 4
Development phase
941
Enrollment target
20
Study locations

NCT00949884 is a Phase 4 study of Hypertension that has completed, run by Daiichi Sankyo. The registered enrollment target is 941 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (73% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00949884, a Phase 4 study of Hypertension, has completed, sponsored by Daiichi Sankyo.

COMPLETED
Registry status
Phase 4
Development phase
941 participants
Enrollment target
20
Study locations

Study Summary

This study will evaluate the efficacy and safety of the FDA approved blood pressure medication olmesartan medoxomil compared to the FDA approved medication losartan potassium.

Conditions Studied

Hypertension

Interventions

  • DRUG Placebo
  • DRUG olmesartan medoxomil
  • DRUG losartan potassium

Study Locations (20)

California

  • - Harbor City
  • - Tustin
  • - Westlake Village

Arizona

  • - Mesa
  • - Phoenix

Florida

  • - Deerfield Beach
  • - DeLand

Tennessee

  • - Bristol
  • - New Tazewell

Colorado

  • - Pueblo

Indiana

  • - South Bend

Kansas

  • - Wichita

Louisiana

  • - Metairie

Trial Details

FieldValue
Enrollment Target 941 participants
Start Date 2009-08
Est. Completion 2010-01
Phase Phase 4

Sponsor

Daiichi Sankyo

236 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00949884

The ClinicalTrials.gov registry entry for NCT00949884 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 941 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (73% lower). The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00949884 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT00949884 about?

NCT00949884 is a clinical study titled "Olmesartan Comparison to Losartan in Hypertensive Subjects". This study will evaluate the efficacy and safety of the FDA approved blood pressure medication olmesartan medoxomil compared to the FDA approved medication losartan potassium.

What is the current status of trial NCT00949884?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 941 participants. The study started on 2009-08. Estimated completion is 2010-01.

What conditions does trial NCT00949884 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00949884?

The interventions under investigation include: Placebo (DRUG), olmesartan medoxomil (DRUG), losartan potassium (DRUG).

Who is sponsoring clinical trial NCT00949884?

This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00949884 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.